欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/4722/002
药品名称Oxycodon/Naloxon Krka 20 mg/10 mg Retardtabletten
活性成分
    • naloxone hydrochloride 10.9 mg
    • oxycodone hydrochloride 20.0 mg
剂型Prolonged-release tablet
上市许可持有人KRKA d.d. NOVO mesto Smarjeska cesta 6 SLO-8501 Novo Mesto Slovenia
参考成员国 - 产品名称Germany (DE)
Oxycodon/Naloxon Krka 20 mg/10 mg Retardtabletten
互认成员国 - 产品名称
    • Denmark (DK)
      Oxycodon/Naloxon Krka
    • Belgium (BE)
      Oxycodon/Naloxon Krka 20 mg/10 mg tabletten met verlengde afgifte
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Portugal (PT)
    • Sweden (SE)
    • Finland (FI)
    • Poland (PL)
      Oxynador
    • Latvia (LV)
      Oxynador 20 mg + 10 mg ilgstošās darbības tabletes
    • Lithuania (LT)
      Dolnada 20 mg / 10 mg pailginto atpalaidavimo tabletės
    • Estonia (EE)
      NOLDOXEN
    • Hungary (HU)
      OXYNADOR 20 mg/10 mg retard tabletta
    • Bulgaria (BG)
      Adolax 20 mg/ 10 mg prolonged-release tablets
    • Czechia (CZ)
      Adolax 20 mg/10 mg, Tableta s prodlouženým uvolňováním
    • Romania (RO)
    • Slovakia (SK)
      Adolax 20 mg/10 mg
    • Slovenia (SI)
      Adolax 20 mg/10 mg tablete s podaljšanim sproščanjem
    • Croatia (HR)
      Adolax 20 mg/10 mg tablete s produljenim oslobađanjem
    • Spain (ES)
许可日期2017/03/24
最近更新日期2022/07/07
药物ATC编码
    • N02AA55 oxycodone and naloxone
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase